Literature DB >> 3122385

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.

H Tighe1, P J Friend, S J Collier, M Decurtins, S Lim, S P Cobbold, S Thiru, R Y Calne, H Waldmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3122385     DOI： 10.1097/00007890-198801000-00047

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

Review 1.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.

Authors:  V Kyle; R J Coughlan; H Tighe; H Waldmann; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation.

Authors:  Junichiro Sageshima; Gaetano Ciancio; Linda Chen; George W Burke
Journal:  Biologics       Date:  2009-07-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.